cabazitaxel accord
accord healthcare s.l.u. - kabazitaxel - prosztata daganatok, kasztráció-rezisztens - daganatellenes szerek - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.
abiraterone accord
accord healthcare s.l.u. - abirateron-acetát - prosztatikus daganatok - endokrin terápia - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateron-acetát - prosztatikus daganatok - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateron-acetát - prosztatikus daganatok - endokrin terápia - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
herwenda
sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - daganatellenes szerek - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).
omicral 100 mg kemény kapszula
bausch health ireland ltd. - itrakonazol -
epirubicin sandoz 2 mg/ml koncentrátum oldatos injekcióhoz és infúzióhoz
sandoz hungária kft. - epirubicin -
nizoral 200 mg tabletta
janssen-cilag kft. - ketokonazol -
holoxan 1000 mg por oldatos injekcióhoz
baxter (hungary) kft. - ifosfamide -
holoxan 2000 mg por oldatos injekcióhoz
baxter (hungary) kft. - ifosfamide -